Craig T. Martin | Professor of Chemistry
University of Massachusetts Amherst

Craig T. Martin is a Professor of Chemistry at the University of Massachusetts Amherst, where he has led innovative research aimed at understanding structure and mechanism in T7 RNA polymerase, the enzyme widely used for RNA synthesis and manufacturing. With a Ph.D. in Chemistry and over 35 years of experience in academia, Dr. Martin's work has touched all aspects of this complex process, but about 10 years ago, he pivoted towards using that deep understanding to improving RNA manufacturing, with a particular emphasis on ultra high purity and eliminating dsRNA at synthesis (his tag line is "an ounce of prevention is worth a pound of purification"). As a speaker at Advanced Therapies USA 2026, Dr. Martin will share a novel mRNA manufacturing platform being developed at Waterfall Scientific, where he serves as co-founder and CSO. The approach is equally suited to personalized mRNA therapeutics, as well as to scaled-out GMP production of large patient based therapies. Attendees can expect to gain valuable knowledge from Dr. Martin's expertise and contribute to the ongoing dialogue surrounding the exciting future of mRNA therapies.